Prodotto aggiunto correttamente al carrello.

discount label
Salivary peptide gSG6-P1
Visualizzare in 3D

Biosynth logo

Salivary peptide gSG6-P1

Rif. 3D-PP42840

1mg
422,00 €
10mg
455,00 €
100mg
925,00 €
Consegna stimata in Stati Uniti, il Lunedì 03 Febbraio 2025

Informazioni sul prodotto

Nome:
Salivary peptide gSG6-P1
Sinonimi:
  • H-EKVWVDRDNVYCGHLDCTRVATF-OH H-Glu-Lys-Val-Trp-Val-Asp-Arg-Asp-Asn-Val-Tyr-Cys-Gly-His-Leu-Asp-Cys-Thr-Arg-Val-Ala-Thr-Phe-OH
Descrizione:

Peptide Salivary peptide gSG6-P1 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Salivary peptide gSG6-P1 include the following: Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein VC Chen, L Chao, J Chao - Journal of Biological Chemistry, 2000 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)55977-4/abstract Deconvoluting the Structural and Drug-Recognition Complexity of the G-Quadruplex-Forming Region Upstream of the bcl-2 P1 Promoter TS Dexheimer , D Sun, LH Hurley - Journal of the American , 2006 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja0563861 Asymptotic Telegrapher's Equation (P1) Approximation for the Transport Equation SI Heizler - Nuclear science and engineering, 2010 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.13182/NSE09-77 The i-Motif in the bcl-2 P1 Promoter Forms an Unexpectedly Stable Structure with a Unique 8:5:7 Loop Folding Pattern S Kendrick , Y Akiyama, SM Hecht - Journal of the American , 2009 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja9076292 P1 or P1¯? Or something else? RE Marsh - Acta Crystallographica Section B: Structural Science, 1999 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?bk0068 The P1' specificity of tobacco etch virus protease RB Kapust, J Tözser , TD Copeland - and biophysical research , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02005740 A new bacteriophage P1-derived vector for the propagation of large human DNA fragments PA Loannou, CT Amemiya , J Garnes, PM Kroisel - Nature , 1994 - nature.comhttps://www.nature.com/articles/ng0194-84 Bacteriophage P1 site-specific recombination: I. Recombination between loxP sites N Sternberg, D Hamilton - Journal of molecular biology, 1981 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0022283681903752 Bacteriophage P1 cloning system for the isolation, amplification, and recovery of DNA fragments as large as 100 kilobase pairs. N Sternberg - Proceedings of the National Academy of , 1990 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.87.1.103 Solution equilibria of the i-motif-forming region upstream of the B-cell lymphoma-2 P1 promoter N Khan , A Avia+M951 , R Tauler , C Gonzalez , R Eritja - Biochimie, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0300908407002027 Non-spatial attentional effects on P1 MJ Taylor - Clinical neurophysiology, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1388245702003097 Genome of bacteriophage P1 MB à obocka , DJ Rose, G Plunkett III - Journal of , 2004 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jb.186.21.7032-7068.2004 Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries MA Mathieu, M Bogyo , CR Caffrey, Y Choe - Molecular and , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166685102000269 Arg-Gly-Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1 M Aumailley, M Gurrath, G Muller, J Calvete , R Timpl - FEBS letters, 1991 - Elsevierhttps://www.sciencedirect.com/science/article/pii/001457939181101D E. coli Genome Manipulation by P1 Transduction LC Thomason, N Costantino - Current protocols in , 2007 - Wiley Online Libraryhttps://currentprotocols.onlinelibrary.wiley.com/doi/abs/10.1002/0471142727.mb0117s79 Symmetry determination following structure solution in P1 L Palatinus , A van der Lee - Journal of Applied Crystallography, 2008 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?db5046 New Brazilian variant of the SARS-CoV-2 (P1/Gamma) of COVID-19 in Alagoas state JC da Silva , VB Felix , SABF Leo - Brazilian Journal of , 2021 - SciELO Brasilhttps://www.scielo.br/j/bjid/a/c4vhXLBKnZQKkQd83H3JxMS/ Efficacy, safety, and immunogenicity of a meningococcal group B (15: P1. 3) outer membrane protein vaccine in Iquique, Chile J Boslego, J Garcia, C Cruz, W Zollinger, B Brandt - Vaccine, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0264410X9400037N Cementum protein 1-derived peptide (CEMP 1-p1) modulates hydroxyapatite crystal formation in vitro G Montoya, R Correa , J Arenas , L Hoz - Journal of Peptide , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3211 Impact of ectoenzymes on p2 and p1 receptor signaling F Kukulski, SA Levesque , J Sevigny - Advances in pharmacology, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780123855268000096 Transduction of linked genetic characters of the host by bacteriophage P1. ES Lennox - 1955 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/19562701727 Case study of two post vaccination SARS-CoV-2 infections with P1 variants in CoronaVac vaccinees in Brazil CF Estofolete, CA Banho , GRF Campos , BC Marques - Viruses, 2021 - mdpi.comhttps://www.mdpi.com/1999-4915/13/7/1237 First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites A Poinsignon , B Samb, S Doucoure - Tropical Medicine & , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-3156.2010.02611.x

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

Peso molecolare:
2,727.07 g/mol
Formula:
C119H180N34O36S2
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP42840 Salivary peptide gSG6-P1

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".